Regions Financial Corp’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.8M | Buy |
30,961
+1,372
| +5% | +$115K | 0.02% | 307 |
|
|
2026
Q1 | $2.37M | Buy |
29,589
+348
| +1% | +$28.7K | 0.02% | 340 |
|
|
2025
Q4 | $2.49M | Sell |
29,241
-1,159
| -4% | -$95.1K | 0.02% | 340 |
|
|
2025
Q3 | $2.36M | Sell |
30,400
-1,351
| -4% | -$106K | 0.02% | 362 |
|
|
2025
Q2 | $2.48M | Sell |
31,751
-2,622
| -8% | -$196K | 0.02% | 348 |
|
|
2025
Q1 | $2.49M | Sell |
34,373
-1,661
| -5% | -$119K | 0.02% | 327 |
|
|
2024
Q4 | $2.67M | Sell |
36,034
-2,689
| -7% | -$188K | 0.02% | 321 |
|
|
2024
Q3 | $2.56M | Sell |
38,723
-34,258
| -47% | -$2.49M | 0.02% | 336 |
|
|
2024
Q2 | $6.74M | Sell |
72,981
-1,852
| -2% | -$164K | 0.05% | 190 |
|
|
2024
Q1 | $7.15M | Sell |
74,833
-3,776
| -5% | -$317K | 0.05% | 191 |
|
|
2023
Q4 | $5.99M | Sell |
78,609
-2,932
| -4% | -$204K | 0.05% | 203 |
|
|
2023
Q3 | $5.65M | Sell |
81,541
-5,387
| -6% | -$433K | 0.05% | 196 |
|
|
2023
Q2 | $8.2M | Sell |
86,928
-4,661
| -5% | -$405K | 0.07% | 171 |
|
|
2023
Q1 | $7.58M | Buy |
91,589
+2,432
| +3% | +$191K | 0.07% | 171 |
|
|
2022
Q4 | $6.65M | Sell |
89,157
-2,928
| -3% | -$226K | 0.06% | 175 |
|
|
2022
Q3 | $7.61M | Buy |
92,085
+209
| +0.2% | +$20.1K | 0.08% | 164 |
|
|
2022
Q2 | $8.74M | Sell |
91,876
-3,784
| -4% | -$392K | 0.08% | 156 |
|
|
2022
Q1 | $11.3M | Buy |
95,660
+2,579
| +3% | +$289K | 0.09% | 147 |
|
|
2021
Q4 | $12.1M | Buy |
93,081
+663
| +0.7% | +$77.3K | 0.09% | 145 |
|
|
2021
Q3 | $10.5M | Sell |
92,418
-2,440
| -3% | -$279K | 0.09% | 153 |
|
|
2021
Q2 | $9.82M | Sell |
94,858
-2,850
| -3% | -$269K | 0.08% | 151 |
|
|
2021
Q1 | $8.17M | Buy |
97,708
+4,185
| +4% | +$354K | 0.07% | 160 |
|
|
2020
Q4 | $8.53M | Buy |
93,523
+439
| +0.5% | +$36.4K | 0.08% | 162 |
|
|
2020
Q3 | $7.43M | Buy |
93,084
+7,400
| +9% | +$577K | 0.08% | 160 |
|
|
2020
Q2 | $5.92M | Buy |
85,684
+15,472
| +22% | +$1.1M | 0.07% | 172 |
|
|
2020
Q1 | $4.42M | Buy |
70,212
+8,904
| +15% | +$642K | 0.06% | 188 |
|
|
2019
Q4 | $4.77M | Sell |
61,308
-6,153
| -9% | -$480K | 0.05% | 207 |
|
|
2019
Q3 | $4.95M | Sell |
67,461
-390
| -0.6% | -$27.4K | 0.05% | 195 |
|
|
2019
Q2 | $4.18M | Sell |
67,851
-2,148
| -3% | -$130K | 0.05% | 206 |
|
|
2019
Q1 | $4.46M | Sell |
69,999
-27
| -0% | -$1.54K | 0.05% | 199 |
|
|
2018
Q4 | $3.58M | Buy |
70,026
+756
| +1% | +$38.3K | 0.04% | 205 |
|
|
2018
Q3 | $4.02M | Sell |
69,270
-5,412
| -7% | -$265K | 0.04% | 211 |
|
|
2018
Q2 | $3.62M | Sell |
74,682
-2,001
| -3% | -$93.4K | 0.04% | 210 |
|
|
2018
Q1 | $3.57M | Sell |
76,683
-5,880
| -7% | -$255K | 0.04% | 220 |
|
|
2017
Q4 | $3.1M | Buy |
82,563
+11,703
| +17% | +$429K | 0.03% | 246 |
|
|
2017
Q3 | $2.58M | Sell |
70,860
-2,697
| -4% | -$103K | 0.03% | 260 |
|
|
2017
Q2 | $2.9M | Sell |
73,557
-13,335
| -15% | -$487K | 0.03% | 235 |
|
|
2017
Q1 | $2.73M | Buy |
86,892
+77,592
| +834% | +$2.43M | 0.03% | 235 |
|
|
2016
Q4 | $291K | Buy |
9,300
+1,326
| +17% | +$43K | ﹤0.01% | 771 |
|
|
2016
Q3 | $320K | Buy |
7,974
+285
| +4% | +$10.7K | ﹤0.01% | 751 |
|
|
2016
Q2 | $256K | Sell |
7,689
-807
| -9% | -$27.6K | ﹤0.01% | 777 |
|
|
2016
Q1 | $250K | Buy |
8,496
+624
| +8% | +$17.2K | ﹤0.01% | 791 |
|
|
2015
Q4 | $207K | Sell |
7,872
-1,794
| -19% | -$46.6K | ﹤0.01% | 847 |
|
|
2015
Q3 | $229K | Sell |
9,666
-132
| -1% | -$3.19K | ﹤0.01% | 833 |
|
|
2015
Q2 | $233K | Buy |
9,798
+384
| +4% | +$8.67K | ﹤0.01% | 845 |
|
|
2015
Q1 | $224K | Buy |
+9,414
| New | +$211K | ﹤0.01% | 844 |
|
Other funds holding EW
Regions Financial Corp's EW Position: Q2 2026 in Review
Regions Financial Corp increased its Edwards Lifesciences (EW) stake by 4.6% in Q2 2026, buying an estimated $115K and bringing the position to 30,961 shares worth $2.8M. The position accounts for 0.02% of the portfolio, ranked #307.
Regions Financial Corp first reported a position in EW in Q1 2015 and has held it in 46 quarters since. The position peaked at $12.1M in Q4 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Regions Financial Corp held 30,961 shares of Edwards Lifesciences worth $2.8M as of Q2 2026.
- Regions Financial Corp bought 1,372 Edwards Lifesciences shares in Q2 2026, an estimated $115K.
- Edwards Lifesciences made up 0.02% of Regions Financial Corp's portfolio in Q2 2026, its #307 holding.
- Regions Financial Corp first reported a position in Edwards Lifesciences in Q1 2015 and has held it in 46 quarters since.
- Regions Financial Corp's Edwards Lifesciences position peaked at $12.1M in Q4 2021.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Regions Financial Corp's 13F filing for Q2 2026, filed 10 Aug 2026.